Back to
Trexquant Investment LP
BBIO
Showing 2 of 15 quarters
Position history for
Trexquant Investment LP's holdings in BridgeBio Pharma, Inc.
No. Trexquant Investment exited its BBIO (BridgeBio Pharma) position in Q4 2024. Its Q3 2024 13F listed 32,930 shares worth $838,398. Trexquant Investment first reported BBIO in Q2 2020 and held it in 10 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$838,398
Total Shares Change
-32,930
Quarter-by-Quarter History